AH

Aimei Health Technology Co., Ltd

AFJK·NASDAQ

$40.87

-5.0%
Financial ServicesShell Companies

Aimei Health Technology Co., Ltd does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities. It intends to acquires businesses in the biopharmaceutical, medical technology/device industries or diagnostic, and other services sectors. Aimei Health Technology Co., Ltd was incorporated in 2023 and is based in New York, New York.

At a Glance

Live Snapshot
Market Cap$250.20M
EPS0.1700
P/E Ratio240.41
Earnings Date05/04/2026

Intrinsic Alpha Methodology

Thesis Lenses

Signal · Driver · Risk

Signal

High confidence

Valuation multiple is elevated (P/E 240.4).

Valuation inputs: P/E 240.4, earnings yield +0.4%, momentum -5.0%.

If multiples stay elevated while momentum fades, downside repricing risk rises.

Driver

High confidence

Return profile is soft (ROE +13.2%, ROIC -7.8%).

Profitability stack: net margin 0.0%, ROE +13.2%, ROIC -7.8%.

Quality deterioration often appears in margins before it shows up in headline EPS.

Risk

High confidence

Risk profile is balanced but has notable pressure points to monitor.

Risk factors: liabilities/assets +33.6%, momentum -5.0%, net margin 0.0%.

Higher leverage with weak momentum and thin margins can amplify drawdown severity.

a

Aimei Health Technology Co., Ltd Market vs Earnings Trajectory

AFJK · NASDAQ

Loading price and EPS data...

AH

Aimei Health Technology Co., Ltd Fair Value Envelope

AFJK · NASDAQ

Our analysis suggests that AFJK has a fair value of HIDDEN per share in the Base Case projection. With shares currently trading at $40.87, this represents a potential HIDDEN relative to our calculated worth for Aimei Health Technology Co., Ltd.

Intrinsic Value
Current Price: $40.87
3Y+795.0%
5Y+795.0%
10Y+795.0%

No Revenue Data

AFJK has not reported any revenue values in the available annual periods.

3Y+518.0%
5Y+518.0%
10Y+518.0%
3Y-
5Y-
10Y-
3Y-83.0%
5Y-83.0%
10Y-83.0%
AH

Aimei Health Technology Co., Ltd Profit Bridge

AFJK · NASDAQ
Revenue0.00
Cost of Goods Sold (0.00)
Gross Profit0.00
Operating Expenses (835.76K)
Operating Income-835.76K
Interest Expense (0.00)
Other Income/Expense1.90M
Pretax Income1.06M
Income Tax (0.00)
Net Income1.06M
Net Income
1.06M

Profitability Analysis

No Gross Profit Margin Data

AFJK has not reported any gross profit margin values in the available annual periods.

No Operating Profit Margin Data

AFJK has not reported any operating profit margin values in the available annual periods.

No Net Profit Margin Data

AFJK has not reported any net profit margin values in the available annual periods.

13.18%
Return on Equity
273%
3Y+5264.0%
5Y+5264.0%
10Y+5264.0%
8.76%
Return on Assets
153%
3Y+3500.0%
5Y+3500.0%
10Y+3500.0%
-7.77%
Return on Invested Capital
434%
3Y+19134.0%
5Y+19134.0%
10Y+19134.0%
A

Aimei Health Technology Co., Ltd Cash Conversion Engine

AFJK · NASDAQ
Net Income1.06M
Depreciation & Amortization0.00
Stock-Based Compensation0.00
Change in Working Capital0.00
Others-1.62M
Capital Expenditures0.00
Free Cash Flow-565.10K

Cash Flow Quality Analysis

FCF Conversion Rate

-53.3%

Negative free cash flow despite positive earnings raises concerns about cash generation ability or heavy capital requirements.

FCF Growth Trend

+15.9%

Strong FCF growth demonstrates improving cash generation and business momentum. Positive signal for sustainability.

Working Capital Impact

+$0.00

Neutral working capital impact. Changes in current assets and liabilities balanced out.

Cash Flow Quality Insight

Cash flow concerns: Despite profitability, the company is burning cash. Review working capital management, CapEx levels, and sustainability of current operations.

a

Aimei Health Technology Co., Ltd Funding & Solvency Profile

AFJK · NASDAQ
Cash & Cash Equivalents2.93K
Net Receivables0.00
Inventory0.00
Other Current Assets0.00
Total Current Assets3 K
Property, Plant & Equipment0.00
Goodwill & Intangible Assets0.00
Long-Term Investments12.10M
Other Non-Current Assets0.00
Total Non-Current Assets12 M
Total Assets
12.10M

Financial Health Analysis

Current Ratio

0.00x

Warning: Liquidity concerns. Current assets may not be sufficient to cover short-term obligations.

Debt-to-Equity Ratio

0.51x

Balanced capital structure with moderate leverage. Equity exceeds debt, suggesting healthy financial stability.

Working Capital

-3368731

Negative working capital indicates short-term liabilities exceed short-term assets—potential liquidity stress.

Asset Composition

0% Current

Capital-intensive business with significant long-term investments in property, equipment, or intangibles.

Financial Health Insight

Negative working capital with limited cash reserves requires immediate attention—potential liquidity crisis if not addressed promptly.

a

Aimei Health Technology Co., Ltd Street Expectations Map

AFJK · NASDAQ

No Target Data

No analyst price targets available for afjk.

a

Aimei Health Technology Co., Ltd Insider Positioning

AFJK · NASDAQ

During the last 12 months, there has been no insider trading activity reported for AFJK.

3 Months

Bought

0

0.00

Sold

0

0.00

Net Activity

+0

+$0

3-6 Months

Bought

0

0.00

Sold

0

0.00

Net Activity

+0

+$0

6-9 Months

Bought

0

0.00

Sold

0

0.00

Net Activity

+0

+$0

9-12 Months

Bought

0

0.00

Sold

0

0.00

Net Activity

+0

+$0

Top Buyers

No buying activity

Top Sellers

No selling activity

Insider Activity Analysis

Net Insider Sentiment

Neutral

No insider trading activity reported. This could indicate blackout periods, lack of conviction, or regulatory restrictions.

Insider Participation

No Activity

No insider trading activity reported from any insiders in the past year.

No Dividend Yield Data

AFJK has not reported any dividend yield values in the available annual periods.

 

afjk Dividend History

AFJK
10Y CAGR +0%
Latest $0
Annual $0
Stable dividend payments
Last Period: +0%